<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03663537085727</udiDi>
    <basicUdiDi>366353700002AR</basicUdiDi>
    <tradeName>Imidazole buffer</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020903</emdnCode>
    <emdnDescription>BUFFERS (HAEMOSTASIS)</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>AM949007</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:09.550Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537083358</udiDi>
    <basicUdiDi>366353700076BN</basicUdiDi>
    <tradeName>FIBRIPHEN™ LRT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020201</emdnCode>
    <emdnDescription>FIBRINOGEN ASSAYS (FACTOR I)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CK585K</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:08.784Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537064654</udiDi>
    <basicUdiDi>366353700056BG</basicUdiDi>
    <tradeName>BIOPHEN™ FIX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020208</emdnCode>
    <emdnDescription>COAGULATION FACTOR IX</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221806</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:07.952Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537047329</udiDi>
    <basicUdiDi>366353700058BL</basicUdiDi>
    <tradeName>BIOPHEN™ FVIII</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020207</emdnCode>
    <emdnDescription>COAGULATION FACTOR VIII</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221406</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:03.948Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537046810</udiDi>
    <basicUdiDi>366353700046BD</basicUdiDi>
    <tradeName>ZYMUTEST™ HIA (Heparin Induced Antibodies) MonoStrip IgGAM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020615</emdnCode>
    <emdnDescription>COAGULATION INHIBITORS/THROMBOPHILIA MARKERS FOR HEPARIN INDUCED THROMBOCYTOPENIA TEST (HIT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK041D</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:03.160Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537042232</udiDi>
    <basicUdiDi>366353700065BH</basicUdiDi>
    <tradeName>CEPHEN™</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020102</emdnCode>
    <emdnDescription>ACTIVATED PARTIAL THROMBOPLASTIN TIME</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CK515L</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:02.349Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537018763</udiDi>
    <basicUdiDi>366353700040AZ</basicUdiDi>
    <tradeName>ZYMUTEST™ HIA (Heparin Induced Antibodies) IgG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020615</emdnCode>
    <emdnDescription>COAGULATION INHIBITORS/THROMBOPHILIA MARKERS FOR HEPARIN INDUCED THROMBOCYTOPENIA TEST (HIT)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>RK040A</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:28:01.551Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537085468</udiDi>
    <basicUdiDi>366353700076BN</basicUdiDi>
    <tradeName>Revohem™ FIB LRT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020201</emdnCode>
    <emdnDescription>FIBRINOGEN ASSAYS (FACTOR I)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CY738219</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:18:20.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537087165</udiDi>
    <basicUdiDi>366353700097BW</basicUdiDi>
    <tradeName>Revohem™ FVIII Bovine</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020207</emdnCode>
    <emdnDescription>COAGULATION FACTOR VIII</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CQ907801</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:11.589Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537082382</udiDi>
    <basicUdiDi>366353700013AW</basicUdiDi>
    <tradeName>BIOPHEN™ Edoxaban Calibrator Low</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020701</emdnCode>
    <emdnDescription>CALIBRATION PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>226401</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:08.022Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537082368</udiDi>
    <basicUdiDi>366353700031AY</basicUdiDi>
    <tradeName>BIOPHEN™ Edoxaban Control Low</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>225401</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:06.782Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537082320</udiDi>
    <basicUdiDi>366353700006AZ</basicUdiDi>
    <tradeName>LIAPHEN™  vWF: Ag</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020215</emdnCode>
    <emdnDescription>COAGULATION FACTOR VON WILLEBRAND (AG)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>120206</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:05.987Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537072253</udiDi>
    <basicUdiDi>366353700053BA</basicUdiDi>
    <tradeName>BIOPHEN™ AT anti-(h)-Xa LRT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020602</emdnCode>
    <emdnDescription>ANTITHROMBIN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221123</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:05.180Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537047633</udiDi>
    <basicUdiDi>366353700054BC</basicUdiDi>
    <tradeName>BIOPHEN™ DiXaI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020309</emdnCode>
    <emdnDescription>ANTI XA ACTIVITY FOR HEPARIN AND DOAC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221030</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:01.187Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537046445</udiDi>
    <basicUdiDi>366353700017B6</basicUdiDi>
    <tradeName>BIOPHEN™ Rivaroxaban Plasma Calibrator</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020701</emdnCode>
    <emdnDescription>CALIBRATION PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>222701</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:42:00.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537068799</udiDi>
    <basicUdiDi>366353700027B9</basicUdiDi>
    <tradeName>BIOPHEN™ Apixaban Control Low</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>225201</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:41:59.580Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537068775</udiDi>
    <basicUdiDi>366353700008B5</basicUdiDi>
    <tradeName>BIOPHEN™ Apixaban Calibrator Low</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020701</emdnCode>
    <emdnDescription>CALIBRATION PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>226101</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:41:58.905Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537046421</udiDi>
    <basicUdiDi>366353700037BC</basicUdiDi>
    <tradeName>BIOPHEN™ Rivaroxaban Control Plasma</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>224501</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:41:41.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537045394</udiDi>
    <basicUdiDi>366353700059BN</basicUdiDi>
    <tradeName>BIOPHEN™ Heparin LRT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020309</emdnCode>
    <emdnDescription>ANTI XA ACTIVITY FOR HEPARIN AND DOAC</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221011</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:41:41.122Z</lastUpdated>
  </row>
  <row>
    <udiDi>03663537041723</udiDi>
    <basicUdiDi>366353700028BB</basicUdiDi>
    <tradeName>BIOPHEN™ Arixtra® Control Plasma</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HYPHEN BioMed</manufacturerName>
    <manufacturerSrn>FR-MF-000002214</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf C</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0103020702</emdnCode>
    <emdnDescription>CONTROL PLASMA FOR HAEMOSTASIS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>224001</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-08-05T22:41:40.322Z</lastUpdated>
  </row>
</eudamedExport>